Maintaining adequate protein intake, hydration, resistance training, and gradual weight loss may help optimise skin health during treatment
People on certain medications: If you are taking certain medications, such as blood thinners, thyroid tablets, or anticonvulsants, you should stop taking L-carnitine
Metabolomic tissue signature in human non-alcoholic fatty liver disease identifies protective candidate metabolites
The overlap between medication side effects and disease symptoms demands a more comprehensive approach
Semaglutide (Wegovy) was approved in 2021 and tirzepatide (Zepbound) in 2023
More serious risks include pancreatitis, gallbladder problems, and thyroid concerns